文献速递白内障与屈光手术

前瞻性随机对侧眼对照比较波前优化与波前引导准分子激光原位角膜磨镶术

Prospective, Randomized, Contralateral Eye Comparison of Wavefront-Guided and Wavefront-Optimized Laser in Situ Keratomileusis.
PubMed 文献 · Am J Ophthalmol · 2019-06-04

这项前瞻性随机对侧眼对照临床试验纳入100例近视或复性近视散光患者(200眼),一眼行波前优化(WFO)LASIK、对侧眼行高分辨率波前引导(WFG)LASIK,比较12个月结果。两种手术均获得优异的术后裸眼远视力且组间无显著差异,但WFG在CDVA增益、低对比度敏感度及更接近正视方面表现更优,WFO在<0.25 D残余散光比例上更高。

要点

  • WFG与WFO术后裸眼远视力均优异,平均UDVA及达到20/16或更佳的比例均无显著差异(P均>0.05)。
  • WFG组CDVA平均增益显著高于WFO组(0.80±0.75行 vs 0.62±0.72行,P=0.04)。
  • WFO组12个月时<0.25 D残余散光比例显著更高(82.5% vs 72.1%,P=0.02),<0.50 D时无显著差异(P=0.61)。

核心结论

  • 波前优化与高分辨率波前引导LASIK均获得优异的视力结果,但基于高分辨率像差仪的治疗在某些方面似乎更优。

研究设计与样本

  • 前瞻性、随机、对侧眼对照临床试验,纳入2015年10月至2017年2月期间接受双侧LASIK的100例近视或复性近视散光患者共200眼,一眼行WFO LASIK、对侧眼行WFG LASIK。
  • 主要结局指标为12个月时的裸眼远视力(UDVA),次要结局包括安全性、可预测性、稳定性、屈光误差、矫正远视力(CDVA)、对比敏感度和高阶像差。

主要发现

  • WFG组CDVA平均增益显著高于WFO组(0.80±0.75行 vs 0.62±0.72行,P=0.04)。
  • WFG组在<5%低对比度敏感度达到>20/40的比例显著更高(37.1%;95%CI 27.5-46.7 vs 24.7%;95%CI 16.2-33.3,P=0.01)。
  • WFG组在<25%低对比度敏感度达到>20/32的比例显著更高(10.3%;95%CI 4.3-16.4 vs 4%;95%CI 0.0-8.1,P=0.04)。
  • WFO组12个月时<0.25 D残余散光比例显著更高(82.5%;95%CI 75.0-90.0 vs 72.1%;95%CI 63.2-81.2,P=0.02),<0.50 D时两组无显著差异(95.6%;95%CI 91.9-99.8 vs 96.9%;95%CI 93.5-100,P=0.61)。
  • WFG组在所有时间点的球镜和等效球镜均更接近正视,三叶草像差显著低于WFO组且显著低于术前测量。

关键数值与推荐

  • 两种手术术后UDVA均优异,平均UDVA及达到特定UDVA(如20/16或更佳)的比例均无显著差异(P均>0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare outcomes in wavefront-optimized (WFO) laser in situ keratomileusis (LASIK) to high-resolution wavefront-guided (WFG) LASIK. DESIGN: Randomized, fellow eye controlled, clinical trial. METHODS: A total of 200 eyes of 100 patients with myopia or compound myopic astigmatism undergoing bilateral LASIK between October 2015 and February 2017 underwent wavefront-optimized (WFO) LASIK in 1 eye and wavefront-guided (WFG) LASIK in the fellow eye. Each eye was evaluated for uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), contrast sensitivity, refractive error, and wavefront aberrometry. Outcome measurement primarily UDVA at 12 months. Secondary outcomes were safety, predictability, stability, refractive error, CDVA, contrast sensitivity, and higher-order aberrations at 12 months. RESULTS: WFG LASIK had higher levels of supervision and better contrast sensitivity compared to WFO. Both types had excellent postoperative UDVA results, without a significant difference in either mean UDVA or frequency of achieving a specified UDVA, for example, 20/16 or better (all P > 0.05). The mean gain in lines of CDVA was significantly higher in the WFG than in the WFO group (0.80 ± 0.75 vs 0.62 ± 0.72, respectively; P = 0.04). The WFG cohort had significantly better contrast sensitivity for mean and frequency of achieving >20/40 for <5% low-contrast sensitivity (37.1%; 95% confidence interval [CI], 27.5-46.7 vs 24.7%; 95% CI, 16.2-33.3, respectively; P = 0.01) and >20/32 for <25% low-contrast sensitivity (10.3%; 95% CI, 4.3-16.4 vs 4%, respectively; 95% CI, 0.0-8.1, respectively; P = 0.04). The WFO group had a significantly higher frequency of <0.25 diopters (D) of refractive astigmatism at 12 months (82.5%; 95% CI, 75.0-90.0; vs 72.1%, respectively; 95% CI, 63.2-81.2; P = 0.02) but not <0.50 D (95.6%; 95% CI, 91.9-99.8; vs 96.9, respectively; 95% CI, 93.5-100; P = 0.61). The WFG group was significantly closer to emmetropia for both sphere and spherical equivalents at all time points. Trefoil was significantly lower in the WFG group and was also significantly lower than preoperative measurements. CONCLUSIONS: Wavefront-optimized and high-resolution wavefront-guided LASIK achieve excellent visual outcomes. Nonetheless, treatments based on a high-resolution aberrometer appear to offer superior results in some regards.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Roe JR, Manche EE. Prospective, Randomized, Contralateral Eye Comparison of Wavefront-Guided and Wavefront-Optimized Laser in Situ Keratomileusis. Am J Ophthalmol. 2019. PMID: 31173739. doi:10.1016/j.ajo.2019.05.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。